Mild to severe heart muscle impairment linked to higher stroke riskJune 02, 2006American Heart Association rapid access journal report Mild, often symptomless, impaired heart function may predispose a person to ischemic stroke, investigators report in Stroke: Journal of the American Heart Association. Having any degree of impaired heart function, known as left ventricular dysfunction (LVD), was almost five times more common in stroke patients than age-matched controls. Although previous studies have linked heart failure to increased stroke risk, this is the first evidence that even mildly impaired heart function may be an independent risk factor for ischemic stroke. Ischemic strokes are caused by a blood clot that blocks blood flow to a part of the brain. The finding raises the question of whether LVD should be included in the evaluation of a person's stroke risk. Mild, symptomless LVD is present in 3 percent to 6 percent of the general population, according to this study. "Clinically overt heart failure has been associated with an increased risk of stroke," said Marco R. Di Tullio, M.D., senior author of the study and professor of clinical medicine at Columbia University in New York. "Mild and often asymptomatic LVD is not usually among the things we consider to predict stroke risk. These results suggest that maybe it should be." In LVD, the heart fails to pump blood as effectively as a normal-functioning heart. Associations between impaired heart function and stroke have come primarily from studies of patients who survived heart attacks. The association between LVD and stroke in the general population had not been as clearly evaluated in any large studies. Researchers compared rates of LVD in stroke patients and in controls enrolled in the Northern Manhattan Study (NOMAS). The analysis focused on 558 NOMAS participants who underwent echocardiography, a test that uses soundwave technology to test heart functioning. The study group comprised 270 stroke patients with first time ischemic stroke (average age 70) and 288 stroke-free participants (average age 69) who were matched with the patients according to age, gender and ethnicity or race. Echocardiography was performed within three days from stroke onset in the stroke group. Reflecting the multiethnic makeup of NOMAS, about 32 percent of the study group was black, 49 percent was Hispanic, and 17 percent was white. Stroke risk factors, such as high blood pressure, smoking and atrial fibrillation (rapid, irregular heartbeat), were more common in one or more ethnic groups of stroke patients compared to controls, and diabetes was more common in stroke patients across all ethnic/race groups. Using echocardiography, researchers documented LVD in 24.1 percent of stroke patients and 4.9 percent of the control group. Regardless of its severity, LVD was significantly more common in stroke patients than in controls. It was moderate-severe in 13.3 percent of stroke patients compared to 2.4 percent of controls; and it was mild in 10.7 percent of stroke patients versus 2.4 percent of the controls. After controlling for the influence of other stroke risk factors, LVD remained a statistically significant predictor of increased stroke risk. LVD had a significant effect on stroke risk across the entire spectrum of patients. LVD of any degree increased the odds of stroke more than three-fold in men, almost five-fold in women, over three-fold in patients under age 70, and almost five-fold in patients 70 and older. The link was also detected in all ethnicities. Di Tullio and his co-authors said results appear to "contradict the belief that stroke risk parallels the severity of LVD, and indicates that a significantly increased risk of stroke should be considered to be present even in the much larger fraction of patients with mildly decreased [LV function]." The finding that even mild LVD increases stroke risk poses a problem because the condition often causes no clear symptoms and is diagnosed incidentally during an evaluation for some unrelated condition, Di Tullio said. The study also poses a treatment-related dilemma. "What to do next [after diagnosing LVD] is not so clear because there is no evidence that treating these patients with the drugs we use to treat heart failure would change the risk of stroke," Di Tullio said. The authors emphasized that further studies are required to assess whether drug treatment could lessen the chance of stroke associated with LVD. How LVD increases ischemic stroke risk is unclear. The researchers are conducting a follow-up study involving stroke-free people who have been evaluated by echocardiography. By following them over time, Di Tullio and his associates hope to further clarify the association between LVD and stroke by defining the annual risk of stroke associated with LVD of different degrees. American Heart Association |
|||||||||||||||||||||
| Related Heart Muscle Current Events and Heart Muscle News Articles Imaging fat layer around heart can help predict disease Imaging epicardial adipose tissue, or the layer of fat around the heart, can provide extra information compared with standard diagnostic techniques such as coronary artery calcium scoring, according to research by cardiologists at Emory University School of Medicine. Researchers discover chemical that may protect hearts of muscular dystrophy patients Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients - a fatal and most common form of muscular dystrophy in children. Oscillations at odds in the heart Researchers in Germany show that a classical biological oscillator, the glycolytic oscillator, may increase damage to the heart during acute loss of oxygen (anoxia), and as may occur during ischemia. Cluster of 'critical' follow-up evaluations may improve outlook for hospitalized HF patients Heart failure is by far the most prevalent chronic cardiac condition. Around 30 million people in Europe have heart failure and its incidence is still increasing: more cases are being identified, more people are living to an old age, and more are surviving a heart attack but with damage to the heart muscle. Bone marrow cell transplants to benefit those with heart disease Two studies published in the latest issue of Cell Transplantation (18:12) may lead to new treatments for the treatment of heart diseases. Black women at increased risk for weakened heart muscle at childbirth Black women are at significantly increased risk for developing a potentially deadly weakening of the heart muscle around the time of childbirth, researchers report. Scientists identify critical enzyme in healthy heart function Scientists are reporting the first-ever data to show that the enzyme calcineurin is critical in controlling normal development and function of heart cells, and that loss of the protein leads to heart problems and death in genetically modified mice. Protein identified that helps heart muscle contract UCSF researchers have discovered that a protein called B1N1 is necessary for the heart to contract. High prevalence of AF found among cross-country skiers Next month, in the Norwegian town of Rena, 12,000 elite cross-country skiers will line up for this year's Birkebeiner ski marathon, an annual endurance race which will take them through 54 kilometres of snow-covered countryside to the winter sports resort of Lillehammer. Studies unclear on role of pre-surgery beta blockers In a commentary appearing in this week's Journal of the American Medical Association, heart specialists at the University of Michigan Health System make a plea for clarity on the best approach for prescribing beta blockers before surgery. More Heart Muscle Current Events and Heart Muscle News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||